VOGLIMAC MF 0.2MG TABLET

VOGLIMAC MF 0.2MG TABLET belongs to the class of anti-diabetic drugs. It is used in the treatment of type 2 diabetes mellitus. Diabetes mellitus is a metabolic disease that causes high blood sugar levels. It occurs when the insulin (a hormone produced by the beta cells of the pancreas) is resistant in breaking the glucose to produce energy (insulin resistance) or the pancreas (an organ behind the stomach) produces little or no insulin at all.

VOGLIMAC MF 0.2MG TABLET is composed of two medicines, namely Voglibose and Metformin. Voglibose belongs to the class of alpha-glucosidase inhibitors. It acts by inhibiting the intestinal enzymes, which break complex sugars into simple sugars such as glucose. This process prevents the rise of blood glucose levels. Metformin belongs to the class of biguanides and exhibits non-pancreatic effect to reduce serum glucose levels without increasing insulin secretion. It is also known as an insulin sensitizer as it increases the effects of insulin. Metformin is considered to be a unique anti-diabetic drug since it does not cause hypoglycemia (lowered blood sugar levels).

Take VOGLIMAC MF 0.2MG TABLET with food at regular intervals as prescribed by your doctor. Your doctor will decide the dosage form, and this may change timely depending on your blood sugar levels. The common side effects of VOGLIMAC MF 0.2MG TABLET include nausea, vomiting, changes in taste, diarrhoea, dizziness, stomach pain, shortness of breath, skin rash, bloating, and flatulence (intestinal wind/gas). Although not everyone experiences these side effects, if they occur, seek medical attention. Lactic acidosis, is a rare, but serious metabolic complication of excess lactic acid in the blood that is caused by metformin accumulation is reported. The risk of lactic acidosis is high in people with kidney, liver, and heart diseases.

Before starting VOGLIMAC MF 0.2MG TABLET, let your doctor know if you have any medical history of anaemia (low hemoglobin levels), seizures (fits), heart, kidney, and liver diseases. VOGLIMAC MF 0.2MG TABLET does not cause hypoglycemia (low blood sugar levels). However, when used with other diabetic drugs like insulin or sulfonylureas, it can lead to hypoglycemia. Also, speak to your doctor if you are on restricted food or fluid intake since VOGLIMAC MF 0.2MG TABLET causes dehydration, low blood sugar, and kidney damage. Do not take VOGLIMAC MF 0.2MG TABLET if you have gastrointestinal diseases like ulcerative colitis or Crohn’s disease. Do not take or stop VOGLIMAC MF 0.2MG TABLET, if the doctor did not advise you to do so.

VOGLIMAC MF 0.2MG TABLET is used to treat type 2 diabetes mellitus. It is a combination of Voglibose and Metformin. Voglibose belongs to the class of alpha-glucosidase inhibitors. It delays glucose absorption by inhibiting the intestinal enzymes, which break complex sugars into simple sugars such as glucose. This process prevents the rise of blood glucose levels immediately after meals. Metformin belongs to the class of biguanides. It shows the non-pancreatic effect to reduce serum glucose levels without increasing insulin secretion. It is also known as an insulin sensitizer as it increases the effects of insulin. It is considered to be a unique anti-diabetic drug since it does not lower blood sugar levels. Metformin does not cause weight gain in most cases.

Common side effects:

• Nausea
• Vomiting
• Changes in taste
• Diarrhoea
• Dizziness
• Stomach pain
• Shortness of breath
• Skin rash
• Bloating
• Flatulence (intestinal wind/gas)

Rare side effects:

• Lactic acidosis

VOGLIMAC MF 0.2MG TABLET may increase the risk of cardiovascular diseases and hypoglycemic conditions in renal and liver disease patients. It can cause pneumatosis intestinalis (gas-filled cysts on the bowel wall) when used along with other alpha-gastrointestinal drugs. It is advised to monitor the gastrointestinal side effects thoroughly to rule out the possibility of pneumatosis intestinalis. VOGLIMAC MF 0.2MG TABLET has an increased risk of lactic acidosis (a rare, but serious metabolic complication of excess lactic acid in the blood that is caused by metformin accumulation). The risk of lactic acidosis is high in older people with kidney, liver, and heart diseases. Hence, brief your medical history and take advice from your doctor before starting VOGLIMAC MF 0.2MG TABLET. Avoid consuming excessive alcohol as it can potentiate lactic acidosis.

• SELEGILINE
• PREDNISOLONE
• PHENYLBUTAZONE
• METOLAZONE
• HYDROCHLOROTHIAZIDE
• METOPROLOL
• PROPRANOLOL
• ISOCARBOXAZID
• PHENELZINE
• CHLOROTHIAZIDE

Regular blood tests are recommended while taking VOGLIMAC MF 0.2MG TABLET to monitor blood sugar levels.

• Maintain a fiber-rich diet and include healthy carbohydrates from fruits, vegetables and whole grains to maintain your blood glucose levels.
• Eat at regular intervals
• Keep a check on your weight and exercise regularly to keep your heart healthy.
• Your doctor also guides you on how to notice and manage the early symptoms of high/low blood sugar levels.
• Gastrointestinal side effects can be managed with simple modifications in your lifestyle. These include cutting down on sugars and fatty foods, and avoiding carbonated drinks and foods that cause gas.